Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marth

Showing results (111-120 of 237) with videos related to

Pageof 24
Sort By:
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
Gynecologic Oncology|January 22, 2011
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancerAlain G Zeimet, Heidi Fiegl, Georg Goebel, et al.
International Journal of Cancer|January 30, 2004
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsAndreas Widschwendter, Lennart Ivarsson, Anya Blassnig, et al.
Molecular Therapy Oncolytics|October 15, 2016
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapyCatherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 23, 2015
Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO AustriaBirgit Volgger, Alain G Zeimet, Alexander Reinthaller, et al.
Journal of Medical Case Reports|July 20, 2011
Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case reportStephan Braun, Daniel Reimer, Isolde Strobl, et al.
Wiener Klinische Wochenschrift|January 8, 2013
Migrants and obstetrics in Austria--applying a new questionnaire shows differences in obstetric care and outcomeWilli Oberaigner, Hermann Leitner, Karin Oberaigner, et al.
Breast Cancer Research and Treatment|July 12, 2008
Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancerDoris Auer, Daniel Reimer, Verena Porto, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
A Prospective Comparison of Subjective Symptoms and Neurophysiological Findings in the Assessment of Neuropathy in Cancer PatientsVera Elisabeth Adreana Kleinveld, Miriam Emmelheinz, Daniel Egle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancerDominik Wolf, Anna M Wolf, Holger Rumpold, et al.
Pageof 24

Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
Gynecologic Oncology|January 22, 2011
DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancerAlain G Zeimet, Heidi Fiegl, Georg Goebel, et al.
International Journal of Cancer|January 30, 2004
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsAndreas Widschwendter, Lennart Ivarsson, Anya Blassnig, et al.
Molecular Therapy Oncolytics|October 15, 2016
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapyCatherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 23, 2015
Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO AustriaBirgit Volgger, Alain G Zeimet, Alexander Reinthaller, et al.
Journal of Medical Case Reports|July 20, 2011
Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case reportStephan Braun, Daniel Reimer, Isolde Strobl, et al.
Wiener Klinische Wochenschrift|January 8, 2013
Migrants and obstetrics in Austria--applying a new questionnaire shows differences in obstetric care and outcomeWilli Oberaigner, Hermann Leitner, Karin Oberaigner, et al.
Breast Cancer Research and Treatment|July 12, 2008
Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancerDoris Auer, Daniel Reimer, Verena Porto, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
A Prospective Comparison of Subjective Symptoms and Neurophysiological Findings in the Assessment of Neuropathy in Cancer PatientsVera Elisabeth Adreana Kleinveld, Miriam Emmelheinz, Daniel Egle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancerDominik Wolf, Anna M Wolf, Holger Rumpold, et al.
Pageof 24